Factors Associated With Study Attrition Among HIV-Infected Risky Drinkers in St. Petersburg, Russia

REFERENCES

• Claus RE, Kindleberger LR, Dugan MC. Predictors of attrition in a longitudinal study of substance abusers. J Psychoactive Drugs. 2002;34(1):69–74.
   PubMed Web of Science ®Google Scholar
• Krishnan A, Wickersham JA, Chitsaz E, et al. Post-release substance abuse outcomes among HIV-infected jail detainees: Results from a multisite study. AIDS Behav. 2012. doi: 10.1007/s10461-012-0362-3.
   Web of Science ®Google Scholar
• Cottler LB, Compton WM, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend. 1996;41(3):209–217.
   PubMed Web of Science ®Google Scholar
• Hansten ML, Downey L, Rosengren DB, Donovan DM. Relationship between follow-up rates and treatment outcomes in substance abuse research: More is better but when is “enough” enough ? Addiction. 2000;95(9): 1403–1416.
   PubMed Web of Science ®Google Scholar
• Harel O, Pellowski J, Kalichman S. Are we missing the importance of missing values in HIV prevention randomized clinical trials? Review and recommendations. AIDS Behav. 2012;16(6)1382-1393. doi: 10.1007/s10461-011-0125-6.
   Web of Science ®Google Scholar
• DiFranceisco W, Kelly JA, Sikkema KJ, Somlai AM, Mur-phy DA, Stevenson LY. Differences between completers and early dropouts from 2 HIV intervention trials: A health belief approach to understanding prevention program attrition. Am J Public Health. 1998;88(7):1068–1073.
   PubMed Web of Science ®Google Scholar
• Johnson MO, Dilworth SE, Neilands TB, et al. Predic-tors of attrition among high risk HIV-infected partici-pants enrolled in a multi-site prevention trial. AIDS Behav. 2008;12(6):974–977. doi: 10.1007/s10461-007-9356-y.
   PubMed Web of Science ®Google Scholar
• Park MJ, Yamazaki Y, Yonekura Y, et al. Predicting com-plete loss to follow-up after a health-education program: Number of absences and face-to-face contact with a researcher. BMC Med Res Methodol. 2011;11: 145-2288-11-145. doi: 10.1186/1471-2288-11-145.
   PubMed Web of Science ®Google Scholar
• Kleschinsky JH, Bosworth LB, Nelson SE, Walsh EK, Shaffer HJ. Persistence pays off: Follow-up methods for difficult-to-track longitudinal samples. J Stud Alcohol Drugs. 2009;70(5):751–761.
   PubMed Web of Science ®Google Scholar
• Scott CK. A replicable model for achieving over 90% fol-low-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend. 2004;74(1):21–36. doi: 10.1016/j. drugalcdep.2003.11.007.
   PubMed Web of Science ®Google Scholar
• Hansen WB, Collins LM, Malotte CK, Johnson CA, Field-ing JE. Attrition in prevention research. J Behav Med. 1985;8(3):261–275.
   PubMed Web of Science ®Google Scholar
• Siddiqui O, Flay BR, Hu FB. Factors affecting attrition in a longitudinal smoking prevention study. Prey Med. 1996;25(5):554–560. doi: 10.1006/pmed.1996.0089.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Wu K, Smurzynski M, et al. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: An AIDS clinical trials group (ACTG) longitudinal linked randomized trials (ALLRT) analysis. HIV Clin Trials. 2011;12(4):190–200. doi: 10.1310/hct1204-190.
   PubMed Web of Science ®Google Scholar
• Graham SM, Shah PS, Aesch ZC, Beyene J, Bayoumi AM. A systematic review of the quality of trials evaluat-ing biomedical HIV prevention interventions shows that many lack power. HIV Clin Trials. 2009;10(6):413–431. doi: 10.1310/hct1006-413.
   PubMed Web of Science ®Google Scholar
• Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–577.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment reten-tion among street-recruited injection drug users. Drug Alcohol Depend. 2004;74(2):177–185. doi: 10.1016/j.dru-galcdep.2003.12.009.
   PubMed Web of Science ®Google Scholar
• Rebeiro P, Althoff KN, Buchacz K, et al. Retention among north american HIV-infected persons in clinical care, 2000–2008. J Acquir Immune Defic Syndr. 2013;62(3):356–362. doi: 10.1097/QA1.0b013e31827f578a.
   PubMed Web of Science ®Google Scholar
• Mugavero MJ, Amico KR, Westfall AO, et al. Early reten-tion in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59(1):86–93. doi: 10.1097/ QAI.0b013e318236f7d2.
   PubMed Web of Science ®Google Scholar
• Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Pad-manabhan L, Stein MD. Discontinuation from HIV medical care: Squandering treatment opportunities. J Health Care Poor Underserved. 2003;14(2):244–255.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Kirk O, Aldins P, et al. Loss to follow-up in an international, multicentre observational study. HIV Med. 2008;9(5):261–269. doi: 10.1111/j.1468-1293.2008.00557.x.
   PubMed Web of Science ®Google Scholar
• Messiah A, Navaline H, Davis-Vogel A, Tobin-Fiore D, Metzger D. Sociodemographic and behavioral characteris-tics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users. Am J Epidemiol. 2003;157(10):930–939.
   PubMed Web of Science ®Google Scholar
• Niccolai LM, Verevochkin SV, Toussova OV, et al. Esti-mates of HIV incidence among drug users in St. Peters-burg, Russia: Continued growth of a rapidly expanding epidemic. Eur J Public Health. 2011;21(5):613–619. doi: 10.1093/eurpub/ckq115.
   PubMed Web of Science ®Google Scholar
• Russian Federal AIDS Center. HIV infection in Russian Federation in 2012. http://hivrussia.ru/stat/2012.shtml. Updated 2012. Accessed September 13, 2013.
   Google Scholar
• Andersen JW, Fass R, van der Horst C. Factors associ-ated with early study discontinuation in AACTG studies, DACS 200. Contemp Clin Trials. 2007;28(5):583–592. doi: 10.1016/j.cct.2007.02.002.
   PubMed Web of Science ®Google Scholar
• Radler BT, Ryff CD. Who participates? Accounting for longitudinal retention in the MIDUS national study of health and well-being. J Aging Health. 2010;22(3):307–331. doi: 10.1177/0898264309358617.
   PubMed Web of Science ®Google Scholar
• de Graaf R, BijI RV, Smit F, Ravelli A, Vollebergh WA. Psychiatric and sociodemographic predictors of attrition in a longitudinal study: The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Am J Epidemiol. 2000;152(11)1 039–1047.
   Web of Science ®Google Scholar
• Desmond DP, Maddux JF, Johnson TH, Confer BA. Obtain-ing follow-up interviews for treatment evaluation. J Subst Abuse Treat. 1995;12(2):95–102.
   PubMed Web of Science ®Google Scholar
• Giordano TP, Gifford AL, White AC, Jr, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493–1499. doi: 10.1086/516778.
   PubMed Web of Science ®Google Scholar
• National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician’s Guide: Updated 2005 Edition. Bethesda, MD: National Institutes of Health; 2007.
   Google Scholar
• McKenzie M, Tulsky JP, Long HL, Chesney M, Moss A. Track-ing and follow-up of marginalized populations: A review. J Health Care Poor Underserved. 1999;10(4):409–429.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB. Alcohol Timeline Followback (TLFB) Users’ Manual. Toronto, Canada: Addiction Research Foundation; 1995.
   Google Scholar
• Sobell L, Sobell M. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen JP, eds. Measuring Alcohol Consumption: Psy-chosocial and Biochemical Methods. Totowa, NJ: Humana Press; 1992:41–72.
   Google Scholar
• Needle R, Fisher DG, Weatherby N, et al. The reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9:242–250.
   Web of Science ®Google Scholar
• Weatherby N, Needle R, Cesar H, et al. Validity of self-reported drug use among injection drug users and crack smokers recruited through street outreach. Eval Program Plann. 1994;17:347–355.
   Web of Science ®Google Scholar
• Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–529.
   PubMed Web of Science ®Google Scholar
• Wright K, Naar-King S, Lam P, Templin T, Frey M. Stigma scale revised: Reliability and validity of a brief measure of stigma for HIV+ youth. J Adolesc Health. 2007;40(1):96–98. doi: 10.1016/j.jadohealth.2006.08.001.
   PubMed Web of Science ®Google Scholar
• Raj A, Cheng DM, Levison R, Meli S, Samet JH. Sex trade, sexual risk, and nondisclosure of HIV serostatus: Find-ings from HIV-infected persons with a history of alcohol problems. AIDS Behav. 2006;10(2):149–157. doi: 10.1007/ 510461-005-9050-x.
   PubMed Web of Science ®Google Scholar
• Stein MD, Freedberg KA, Sullivan LM, et al. Sexual ethics. Disclosure of HIV-positive status to partners. Arch Intern Med. 1998;158(3):253–257.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Beck Depression Inventory. 2nd ed. NCS Pearson, Inc. 1996: vi, 38. [Russian transla-tion copyright 0 2007]
   Google Scholar
• Sherbourne CD, Stewart AL. The MOS social support sur-vey. Soc Sci Med. 1991;32(6):705–714.
   PubMed Web of Science ®Google Scholar
• Kalbfleisch JD, Prentice RL, eds. The Statistical Analysis of Failure Time Data. 2nd ed. Hoboken, NJ: Wiley; 2002.
   Google Scholar
• Lebouche B, Yazdanpanah Y, Gerard Y, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med. 2006;7(3):140–145. doi: 10.1111/j.1468-1293.2006.00357.x.
   PubMed Web of Science ®Google Scholar
• Lunze K, Cheng DM, Quinn E, et al. Nondisclosure of HIV infection to sex partners and alcohol’s role: A Rus-sian experience. AIDS Behav. 2013;17(1):390–398. doi: 10.1007/s10461-012-0216-z.
   PubMed Web of Science ®Google Scholar
• Simoni JM, Montoya HD, Huang B, Goodry E. Social sup-port and depressive symptomatology among HIV-positive women: The mediating role of self-esteem and mastery. Women Health. 2005;42(4):1–15.
   PubMed Web of Science ®Google Scholar
• Wohl AR, Galvan FH, Myers HF, et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women ? AIDS Behav. 2011;15(6):1098–1110. doi: 10.1007/s10461-010-9833-6.
   PubMed Web of Science ®Google Scholar
• Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav. 2006;10(3):263–272. doi: 10.1007/s10461-005-9042-x.
   PubMed Web of Science ®Google Scholar
• Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: Implications for preven-tion of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.
   PubMed Web of Science ®Google Scholar
• Walmsley R, International Centre for Prison Studies. World female imprisonment list (2nd ed.). http://www.prisonstud-ies.org/images/news_events/wfil2ndedition.pdf. Updated 2012. Accessed September 13, 2013.
   Google Scholar
• United Nations Office on Drugs and Crime. Women and HIV in prison settings. http://www.unodc.org/documents/hiv-aids/Women%20and%2OHIV%20in%20prison%20set-tings.pdf. Updated 2006. Accessed September 13,2013.
   Google Scholar